Compare Crispr Therapeutics AG (CRSP) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Virgin Galactic Holdings, Inc. — how do they compare? Crispr Therapeutics AG trades at $54.07 (market cap $5.23B), while Virgin Galactic Holdings, Inc. trades at $3.31 (market cap $498.02M). The key difference: Crispr Therapeutics AG is far larger — about 10.5× Virgin Galactic Holdings, Inc.'s market cap. Which is the better fit depends on your goals.
| CRSP | SPCE | |
|---|---|---|
Market Cap | $5.23B | $498.02M |
Sector | Health | Industrials |
52-Week High | $76.78 | $7.52 |
52-Week Low | $44.34 | $2.17 |
Enterprise Value | $3.65B | $597.87M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
